NEON THERAPEUTICS, INC. Comprehensive Income
NEON THERAPEUTICS, INC. reported Comprehensive Income of -$16.60 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-01.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2020-05-01
- NEON THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-03-31 was -$16.60M.
- NEON THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-12-31 was -$17.84M.
- NEON THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-09-30 was -$18.98M.
- NEON THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-06-30 was -$21.92M.
- NEON THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$79.70M.
- NEON THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$77.00M.
- NEON THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was -$47.55M.
- NEON THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2016 was -$27.43M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$16.60M 10-Q · filed 2020-05-01 | -$34.44M derived: sum of 2 quarters · filed 2020-05-01 | -$53.42M derived: sum of 3 quarters · filed 2020-05-01 | -$75.34M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-12-31 | -$17.84M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$36.82M derived: sum of 2 quarters · filed 2020-03-02 | -$58.74M derived: sum of 3 quarters · filed 2020-03-02 | -$79.70M 10-K · filed 2020-03-02 |
| 2019-09-30 | -$18.98M 10-Q · filed 2019-11-12 | -$40.90M derived: sum of 2 quarters · filed 2019-11-12 | -$61.86M 10-Q · filed 2019-11-12 | -$85.03M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-06-30 | -$21.92M 10-Q · filed 2019-08-06 | -$42.88M 10-Q · filed 2019-08-06 | -$66.06M derived: sum of 3 quarters · filed 2020-05-01 | -$84.47M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-03-31 | -$20.96M 10-Q · filed 2020-05-01 | -$44.13M derived: sum of 2 quarters · filed 2020-05-01 | -$62.54M derived: sum of 3 quarters · filed 2020-05-01 | -$81.44M derived: sum of 4 quarters · filed 2020-05-01 |
| 2018-12-31 | -$23.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$41.59M derived: sum of 2 quarters · filed 2020-03-02 | -$60.48M derived: sum of 3 quarters · filed 2020-03-02 | -$77.00M 10-K · filed 2020-03-02 |
| 2018-09-30 | -$18.41M 10-Q · filed 2019-11-12 | -$37.31M derived: sum of 2 quarters · filed 2019-11-12 | -$53.82M 10-Q · filed 2019-11-12 | -$68.30M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$18.89M 10-Q · filed 2019-08-06 | -$35.41M 10-Q · filed 2019-08-06 | -$49.89M derived: sum of 3 quarters · filed 2019-08-06 | -$63.86M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | -$16.52M 10-Q · filed 2019-05-13 | -$30.99M derived: sum of 2 quarters · filed 2019-05-13 | -$44.97M derived: sum of 3 quarters · filed 2019-05-13 | -$54.59M derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | -$14.48M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | -$28.45M derived: sum of 2 quarters · filed 2019-03-11 | -$38.08M derived: sum of 3 quarters · filed 2019-03-11 | -$47.55M 10-K · filed 2019-03-11 |
| 2017-09-30 | -$13.97M 10-Q · filed 2018-11-13 | -$23.60M derived: sum of 2 quarters · filed 2018-11-13 | -$33.07M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | -$9.63M 10-Q · filed 2018-08-06 | -$19.09M 10-Q · filed 2018-08-06 | ||
| 2016-12-31 | -$27.43M 10-K · filed 2019-03-11 |